Jim Cramer's Top Takeaways: BioMarin, Radius Health, Allergan, Diageo, Wayfair

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK (TheStreet) -- Did you miss last night's "Mad Money" on CNBC? If so, here are Jim Cramer's top takeaways for today's trading.

BMRN Chart
BMRN data by YCharts

BioMarin Pharmaceutical (BMRN), Radius Health (RDUS), Allergan (AGN): These biotechs were big winners Thursday, Cramer said. BioMarin and Radius unveiled positive results on its respective drugs while Allergan continues to feel the love from its announced buy of Kythera Biopharmaceuticals (KYTH).

DEO Chart
DEO data by YCharts

Diageo (DEO): Diageo's stock climbed nearly 2% Thursday, and are now up more than 10% over the past two weeks. Why? A report suggested private equity firm 3G Capital was interested in buying the company.

Should you indulge? No way, said Cramer. Diageo, the world's largest producer of hard liquor, "has been a total dog" for the past year and a half, Cramer said. But the idea of a takeover has left many analysts upgrading the stock, including J.P. Morgan, RBC Capital Markets and Credit Suisse.

These analysts felt they had to upgrade the stock because they couldn't risk having a sell rating on a stock that rips higher on a potential takeover announcement, he explained.

However, he said, based on the most recent deals in the space, a potential acquisition could be done at 20 times Diageo's Ebitda for 2014, or $195 per share. That whopping 62% premium seems like too much though, given that sales and shipping volume are on the decline.

W Chart
W data by YCharts

Wayfair (W): Cramer said down with Wayfair CEO Niraj Shah. Shares of the online home goods retailer are up a robust 89% so far on the year. Shah, who spoke at a Goldman Sachs conference on Thursday, said the company is looking for revenue of $2 billion for this year, ahead of analysts' expectations for $1.87 billion.

Shah said the company is using superior technology, marketing, operations and merchandising to get ahead in the online commerce market. "You really have to be great at all of them," he added, because one weak link in those four core areas can really drag down results.

For marketing, the company has relied on Facebook, which has been a success for Wayfair when it comes to getting in front of their key demographic. "It's been a really fantastic platform for us," he said. The company doesn't carry any inventory, which is what allows Wayfair to provide consumers with such a vast selection.

To read a full recap of "Mad Money" on CNBC, click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in AGN.

More from Opinion

AAP Exclusive: Cramer Says The President is No Longer on the Side of the Bulls

AAP Exclusive: Cramer Says The President is No Longer on the Side of the Bulls

Why It Makes Perfect Sense for Netflix and Amazon to Buy Up Movie Theaters

Why It Makes Perfect Sense for Netflix and Amazon to Buy Up Movie Theaters

2 More Reasons to Sell All Your Stocks and Run Away

2 More Reasons to Sell All Your Stocks and Run Away

Sean Hannity's Link to Trump Lawyer Raises Questions: Doug Kass Insider

Sean Hannity's Link to Trump Lawyer Raises Questions: Doug Kass Insider

Netflix Blowout Earnings Remind Investors of One Thing: This Company Is a Beast

Netflix Blowout Earnings Remind Investors of One Thing: This Company Is a Beast